Chris Boshoff

Chris Boshoff

Presidente en SEAGEN INC. .

Fortuna: 4 M $ al 31/05/2026

Health Technology
Commercial Services
Consumer Services

Perfil

Chris Boshoff currently works at Pfizer Inc., as President-R&D & Chief Scientific Officer from 2025, Seagen, Inc., as President from 2023, and Pfizer (La Jolla), as Vice President-Translational Oncology.
Dr. Boshoff also formerly worked at Advanced Oncotherapy Plc, as Non-Executive Director in 2013 and UCL Cancer Institute Research Trust, as Founding Director.
Dr. Boshoff received his doctorate degree from Institute of Cancer Research Royal Marsden Hospital.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
03/03/2026 162.088 ( 0 % ) 4 M $ 31/05/2026

Últimas noticias acerca de Chris Boshoff

Cargos activos de Chris Boshoff

EmpresasCargoInicio
PFIZER INC. Director Técnico/Científico/I+D 01/01/2025
SEAGEN INC. Presidente 14/12/2023
Corporate Officer/Principal -

Antiguos cargos conocidos de Chris Boshoff.

EmpresasCargoFin
ADVANCED ONCOTHERAPY PLC Director/Miembro de la Junta 25/10/2013
UCL Cancer Institute Research Trust
Director/Miembro de la Junta -
Ver el detalle de la experiencia de Chris Boshoff.

Formación de Chris Boshoff.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

25

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Health Technology

Health Technology

Commercial Services

UCL Cancer Institute Research Trust

Consumer Services